Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Almirall, S.A.

Capitalization 2.47B 2.84B 2.23B 2.13B 3.88B 262B 4.01B 26.49B 10.52B 125B 10.64B 10.42B 451B P/E ratio 2026 *
28x
P/E ratio 2027 * 19.6x
Enterprise value 2.32B 2.67B 2.11B 2.01B 3.66B 247B 3.78B 24.97B 9.91B 118B 10.03B 9.82B 425B EV / Sales 2026 *
1.88x
EV / Sales 2027 * 1.61x
Free-Float
35.93%
Yield 2026 *
1.71%
Yield 2027 * 1.81%
1 day+1.06%
1 week-4.17%
Current month-10.87%
1 month-14.33%
3 months-13.68%
6 months+2.68%
Current year-10.59%
1 week 11.24
Extreme 11.24
12.28
1 month 11.24
Extreme 11.24
13.98
Current year 11.24
Extreme 11.24
13.98
1 year 8.65
Extreme 8.65
13.98
3 years 7.16
Extreme 7.16
13.98
5 years 7.16
Extreme 7.16
15.35
10 years 7.16
Extreme 7.16
18.5
Manager TitleAgeSince
Chief Executive Officer - 01/11/2022
Director of Finance/CFO 53 30/08/2025
Chief Tech/Sci/R&D Officer - 06/07/2021
Director TitleAgeSince
Director/Board Member 65 31/12/2012
Director/Board Member - 31/12/2013
Director/Board Member - 31/12/2015
Change 5d. change 1-year change 3-years change Capi.($)
+1.06%-4.17%+11.35%+32.41% 2.79B
+0.41%-0.12%+21.59%+200.22% 880B
+0.69%+1.16%+49.37%+57.56% 582B
+0.81%-3.76%+4.57%+43.74% 388B
+0.50%-5.54%+5.40%+21.46% 324B
-0.11%-0.94%+19.76%+34.95% 295B
+0.07%-1.48%+26.04%+60.91% 293B
+0.58%-0.31%+22.06%+7.25% 286B
+0.01%-0.89%+16.75%+55.92% 197B
+0.15%+0.89%+30.30%+82.31% 180B
Average +0.29%-1.85%+20.72%+59.67% 342.9B
Weighted average by Cap. +0.17%-1.37%+23.28%+84.52%

Financials

2026 *2027 *
Net sales 1.24B 1.42B 1.12B 1.07B 1.95B 131B 2.01B 13.29B 5.28B 62.84B 5.34B 5.22B 226B 1.37B 1.58B 1.25B 1.19B 2.16B 146B 2.24B 14.76B 5.86B 69.84B 5.93B 5.81B 252B
Net income 88.53M 102M 80.22M 76.45M 139M 9.4B 144M 951M 378M 4.5B 382M 374M 16.2B 126M 144M 114M 108M 198M 13.33B 204M 1.35B 536M 6.38B 542M 531M 22.99B
Net Debt -142M -163M -128M -122M -223M -15.04B -230M -1.52B -604M -7.2B -611M -598M -25.93B -259M -297M -234M -223M -407M -27.44B -421M -2.78B -1.1B -13.14B -1.12B -1.09B -47.31B
Logo Almirall, S.A.
Almirall SA is a Spain-based company principally engaged in the pharmaceuticals manufacture. The Company focuses on development and marketing of drugs applied in various therapeutic areas, such as nervous system, gastrointestinal, dermatological, respiratory system, antiinfectives, as well as antineoplastic and immunomodulating agents. The Company's activities are divided into four business segments: Own network, which focuses on the commercialization of pharmaceuticals through own brand names; Licenses, which sells product rights to third parties; Research and development (R&D), which is responsible for the creation of drug candidates, as well as Dermatology, which includes sale of dermatological medicines in the United States. The Company operates through numerous subsidiaries in Europe, the Americas, Africa, Asia and Australia.
Employees
2,108
Date Price Change Volume
16/03/26 11.48 +1.06% 149,875
13/03/26 11.36 -1.73% 136,551
12/03/26 11.56 -1.37% 133,573
11/03/26 11.72 -1.84% 129,111
10/03/26 11.94 +0.84% 129,201
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
11.36EUR
Average target price
14.26EUR
Spread / Average Target
+25.49%

Quarterly revenue - Rate of surprise

SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW